ALAUNOS THERAPEUTICS INC (TCRT) Stock Balance Sheet
NASDAQ:TCRT - Nasdaq - US98973P3091 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 1.09M | 6.06M | 39.06M | 76.05M | 115.07M | |||
| Receivables | 5.00K | 1.00K | 4.00K | 1.11M | 4.67M | |||
| Other Current Assets | 1.66M | 2.20M | 14.74M | 1.67M | 10.86M | |||
| Total Current Assets | 2.75M | 8.26M | 53.80M | 78.83M | 130.59M | |||
| Non-Current Assets | ||||||||
| PPE Net | 0.00 | 2.00K | 10.60M | 15.36M | 14.88M | |||
| Other Non-Current Assets | N/A | 0.00 | 542.00K | 673.00K | 875.00K | |||
| Total Non-Current Assets | 0.00 | 2.00K | 11.14M | 16.03M | 15.76M | |||
| TOTAL ASSETS | 2.75M | 8.26M | 64.94M | 94.86M | 146.34M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 0.00 | 16.77M | 7.87M | N/A | |||
| Accrued Expenses | 176.00K | 1.34M | 6.01M | 6.80M | 17.41M | |||
| Accounts Payable | 516.00K | 616.00K | 1.39M | 1.37M | 960.00K | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 692.00K | 1.96M | 24.17M | 16.04M | 18.37M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 16.25M | 0.00 | |||
| Other Non-Current Liabilities | N/A | 0.00 | 2.22M | 4.52M | 4.00M | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 2.22M | 20.77M | 4.00M | |||
| TOTAL LIABILITIES | 692.00K | 1.96M | 26.38M | 36.81M | 22.36M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -920.45M | -915.77M | -880.63M | -842.85M | -764.10M | |||
| Additional Paid In Capital | 922.51M | 922.06M | 918.94M | 900.69M | 887.87M | |||
| Common Shares | 2.00K | 16.00K | 240.00K | 216.00K | 215.00K | |||
| Shares Outstanding | 1.60M | 16.01M | 16.03M | 14.41M | 14.31M | |||
| Tangible Book Value per Share | 1.29 | 0.39 | 2.41 | 4.03 | 8.67 | |||
| Total Shareholders' Equity | 2.06M | 6.31M | 38.55M | 58.06M | 123.98M | |||
| TOTAL LIABILITIES AND EQUITY | 2.75M | 8.26M | 64.94M | 94.86M | 146.34M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.28 | N/A | |||
| Current Ratio | 3.98 | 4.22 | 2.23 | 4.91 | 7.11 | |||
| Return On Assets (ROA) | -169.84% | -425.27% | -58.10% | -83.01% | -54.65% | |||
| Return On Equity (ROE) | -226.81% | -557.16% | -97.86% | -135.64% | -64.51% | |||
All data in USD , ROIC based on taxRate of 0.21